Harbour BioMed, a global biopharmaceutical company, announced that Nona Biosciences, a subsidiary wholly owned by the company, had entered into a license and collaboration agreement with ModernaTX, Inc., a global biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The strategic collaboration will focus on discovering and developing nucleic acid-based immunotherapies for select oncology targets using the company
